Shattuck Labs, Inc.
STTKHealthcare|Biotechnology|US
$4.62
+0.13 (+2.90%)
DCF Value
$0.61
Tangible Book / Share
$1.06
Cash / Share
$1.07
Ownership Breakdown
85.9%
Float
100.4M
Shares Outstanding
86.2M
Float Shares
Major Holders (20)
Combined: 153.3%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | Investment adviser | 15.30% | 13,432,540 | Aug 14, 2026 | 13D/G |
| Orbimed Advisors LLC | Investment adviser | 9.99% | 9,021,127 | Jun 15, 2026 | 13D/G |
| Redmile Group, LLC | IA, OO | 9.90% | 10,019,421 | Jul 17, 2026 | 13D/G |
| Jeremy C. Green | HC, IN | 9.90% | 10,019,421 | Jul 17, 2026 | 13D/G |
| Prosight Partners, LLC | Other | 9.90% | 6,543,240 | Nov 13, 2025 | 13D/G |
| Prosight Management, LP | Investment adviser | 9.90% | 6,543,240 | Nov 13, 2025 | 13D/G |
| W. Lawrence Hawkins | HC, IN | 9.90% | 6,543,240 | Nov 13, 2025 | 13D/G |
| Robert Atchinson | HC, IN | 9.79% | 4,675,000 | Feb 12, 2025 | 13D/G |
| Phillip Gross | HC, IN | 9.79% | 4,675,000 | Feb 12, 2025 | 13D/G |
| Adage Capital Management, L.P. | IA, PN | 9.79% | 4,675,000 | Feb 12, 2025 | 13D/G |
| OrbiMed Capital GP IX LLC | Other | 8.33% | 7,517,606 | Jun 15, 2026 | 13D/G |
| Redmile Biopharma Investments II, L.P. | Partnership | 8.10% | 8,125,342 | Jul 17, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 5.30% | 5,339,458 | Oct 27, 2026 | 13D/G |
| David Kroin | HC, IN | 5.17% | 5,000,033 | Jun 17, 2026 | 13D/G |
| Deep Track Capital, LP | IA, OO | 5.17% | 5,000,033 | Jun 17, 2026 | 13D/G |
| Deep Track Biotechnology Master Fund, Ltd. | Corporation | 5.17% | 5,000,033 | Jun 17, 2026 | 13D/G |
| Prosight Plus Fund, LP | Partnership | 4.90% | 3,127,182 | Nov 13, 2025 | 13D/G |
| The Vanguard Group | Investment adviser | 4.48% | 2,148,174 | Jul 29, 2025 | 13D/G |
| OrbiMed Genesis GP LLC | Other | 1.67% | 1,503,521 | Jun 15, 2026 | 13D/G |
| Prosight Fund, LP | Partnership | 0.90% | 600,310 | Nov 13, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 126,692,952 acquired · 6,539,175 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer | Jul 6, 2026 | OPTION EX. | 12,153 | $3.57 | $43.4K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 2, 2026 | OPTION EX. | 410 | $3.57 | $1.5K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 2, 2026 | SELL | 410 | $7.01 | $2.9K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 2, 2026 | OPTION EX. | 410 | $3.57 | $1.5K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 6, 2026 | OPTION EX. | 12,153 | $3.57 | $43.4K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jun 30, 2026 | OPTION EX. | 23,365 | $3.57 | $83.4K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 1, 2026 | OPTION EX. | 100 | $3.57 | $357.00 | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 1, 2026 | SELL | 100 | $7.07 | $707.00 | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jun 30, 2026 | SELL | 23,365 | $7.08 | $165.4K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jun 30, 2026 | OPTION EX. | 23,365 | $3.57 | $83.4K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jul 1, 2026 | OPTION EX. | 100 | $3.57 | $357.00 | Form 4 |
| Pandite Arundathy N. | Chief Medical Officer | Jun 30, 2026 | SELL | 30,000 | $7.01 | $210.3K | Form 4 |
| Ashiya Mona | director | Jun 11, 2026 | BUY | 1,041,667 | $0.00 | $104.17 | Form 4 |
| Ashiya Mona | director | Jun 11, 2026 | BUY | 208,333 | $0.00 | $20.83 | Form 4 |
| ORBIMED ADVISORS LLC | director | Jun 11, 2026 | BUY | 1,041,667 | $0.00 | $104.17 | Form 4 |
| ORBIMED ADVISORS LLC | director | Jun 11, 2026 | BUY | 208,333 | $0.00 | $20.83 | Form 4 |
| SIEGALL CLAY B | director | Jun 9, 2026 | BUY | 62,500 | $4.00 | $250.0K | Form 4 |
| ORBIMED ADVISORS LLC | director | Jun 8, 2026 | CONVERSION | 15,366,490 | $0.00 | $1.5K | Form 4 |
| ORBIMED ADVISORS LLC | director | Jun 8, 2026 | CONVERSION | 3,073,298 | $0.00 | $307.33 | Form 4 |
| ORBIMED ADVISORS LLC | director | Jun 8, 2026 | CONVERSION | 3,073,298 | $1.08 | $3.3M | Form 4 |
| Ashiya Mona | director | Jun 8, 2026 | CONVERSION | 15,366,490 | $0.00 | $1.5K | Form 4 |
| Ashiya Mona | director | Jun 8, 2026 | CONVERSION | 3,073,298 | $0.00 | $307.33 | Form 4 |
| Ashiya Mona | director | Jun 8, 2026 | CONVERSION | 3,073,298 | $1.08 | $3.3M | Form 4 |
| Baker Daniel G. | director | May 29, 2026 | AWARD | 81,000 | $5.95 | $481.9K | Form 4 |
| Golumbeski George | director | May 29, 2026 | AWARD | 81,000 | $5.95 | $481.9K | Form 4 |
| Gibson Neil W | director | May 29, 2026 | AWARD | 81,000 | $5.95 | $481.9K | Form 4 |
| Ashiya Mona | director | May 29, 2026 | AWARD | 81,000 | $5.95 | $481.9K | Form 4 |
| SIEGALL CLAY B | director | May 29, 2026 | AWARD | 81,000 | $5.95 | $481.9K | Form 4 |
| Boudreau Helen M | director | May 29, 2026 | AWARD | 81,000 | $5.95 | $481.9K | Form 4 |
| SIEGALL CLAY B | director | May 22, 2026 | AWARD | 128,054 | $1.08 | $138.9K | Form 4 |
| SIEGALL CLAY B | director | May 22, 2026 | OPTION EX. | 128,054 | $1.08 | $138.9K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | May 21, 2026 | AWARD | 5,122 | $1.08 | $5.6K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | May 21, 2026 | OPTION EX. | 5,122 | $1.08 | $5.6K | Form 4 |
| Stout Stephen | See Remarks | May 15, 2026 | AWARD | 12,805 | $1.08 | $13.9K | Form 4 |
| Stout Stephen | See Remarks | May 15, 2026 | OPTION EX. | 12,805 | $1.08 | $13.9K | Form 4 |
| Neill Andrew R | Chief Financial Officer | May 12, 2026 | AWARD | 64,027 | $1.08 | $69.4K | Form 4 |
| Neill Andrew R | Chief Financial Officer | May 12, 2026 | OPTION EX. | 64,027 | $1.08 | $69.4K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | May 12, 2026 | OPTION EX. | 2,032 | $3.57 | $7.3K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | May 12, 2026 | SELL | 2,032 | $7.01 | $14.2K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | May 12, 2026 | OPTION EX. | 2,032 | $3.57 | $7.3K | Form 4 |
| Pandite Arundathy N. | Chief Medical Officer | May 12, 2026 | SELL | 30,000 | $6.61 | $198.3K | Form 4 |
| Schreiber Taylor | director, officer: Chief Executive Officer | May 12, 2026 | AWARD | 25,610 | $1.08 | $27.8K | Form 4 |
| Schreiber Taylor | director, officer: Chief Executive Officer | May 12, 2026 | OPTION EX. | 25,610 | $1.08 | $27.8K | Form 4 |
| Stout Stephen | See Remarks | May 10, 2026 | TAX W/H | 968 | $6.85 | $6.6K | Form 4 |
| Pandite Arundathy N. | Chief Medical Officer | Jan 25, 2026 | TAX W/H | 3,195 | $4.15 | $13.3K | Form 4 |
| Stout Stephen | See Remarks | Jan 25, 2026 | TAX W/H | 593 | $4.15 | $2.5K | Form 4 |
| DeYoung Casi | Chief Business Officer | Jan 25, 2026 | TAX W/H | 2,286 | $4.15 | $9.5K | Form 4 |
| Neill Andrew R | Chief Financial Officer | Jan 25, 2026 | TAX W/H | 2,589 | $4.15 | $10.7K | Form 4 |
| Stout Stephen | See Remarks | Jan 10, 2026 | AWARD | 351,400 | $4.75 | $1.7M | Form 4 |
| Stout Stephen | See Remarks | Jan 10, 2026 | TAX W/H | 4,153 | $4.75 | $19.7K | Form 4 |
| DeYoung Casi | Chief Business Officer | Jan 10, 2026 | AWARD | 381,600 | $4.75 | $1.8M | Form 4 |
| DeYoung Casi | Chief Business Officer | Jan 10, 2026 | TAX W/H | 5,699 | $4.75 | $27.1K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jan 10, 2026 | AWARD | 315,500 | $4.75 | $1.5M | Form 4 |
| Pandite Arundathy N. | Chief Medical Officer | Jan 10, 2026 | AWARD | 487,800 | $4.75 | $2.3M | Form 4 |
| Pandite Arundathy N. | Chief Medical Officer | Jan 10, 2026 | TAX W/H | 6,851 | $4.75 | $32.5K | Form 4 |
| Neill Andrew R | Chief Financial Officer | Jan 10, 2026 | AWARD | 549,800 | $4.75 | $2.6M | Form 4 |
| Neill Andrew R | Chief Financial Officer | Jan 10, 2026 | TAX W/H | 6,660 | $4.75 | $31.6K | Form 4 |
| Schreiber Taylor | director, officer: Chief Executive Officer | Jan 10, 2026 | AWARD | 1,548,300 | $4.75 | $7.4M | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 25, 2025 | BUY | 15,366,490 | $1.08 | $16.7M | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 25, 2025 | BUY | 10,111,384 | $0.00 | $1.0K | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 25, 2025 | BUY | 5,255,106 | $0.87 | $4.6M | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 25, 2025 | BUY | 3,073,298 | $1.08 | $3.3M | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 25, 2025 | BUY | 2,022,277 | $0.00 | $202.23 | Form 4 |
| ORBIMED ADVISORS LLC | director | Aug 25, 2025 | BUY | 1,051,021 | $0.87 | $912.0K | Form 4 |
| Ashiya Mona | director | Aug 25, 2025 | BUY | 15,366,490 | $1.08 | $16.7M | Form 4 |
| Ashiya Mona | director | Aug 25, 2025 | BUY | 10,111,384 | $0.00 | $1.0K | Form 4 |
| Ashiya Mona | director | Aug 25, 2025 | BUY | 5,255,106 | $0.87 | $4.6M | Form 4 |
| Ashiya Mona | director | Aug 25, 2025 | BUY | 3,073,298 | $1.08 | $3.3M | Form 4 |
| Ashiya Mona | director | Aug 25, 2025 | BUY | 2,022,277 | $0.00 | $202.23 | Form 4 |
| Ashiya Mona | director | Aug 25, 2025 | BUY | 1,051,021 | $0.87 | $912.0K | Form 4 |
| ORBIMED ADVISORS LLC | director: | Aug 25, 2025 | OTHER | 0 | — | — | Form 4 |
| Ashiya Mona | director | Aug 28, 2025 | AWARD | 66,300 | $0.99 | $65.6K | Form 4 |
| Baker Daniel G. | director | Aug 28, 2025 | AWARD | 66,300 | $0.99 | $65.6K | Form 4 |
| Baker Daniel G. | Aug 25, 2025 | OTHER | 0 | — | — | Form 4 | |
| Ashiya Mona | Aug 25, 2025 | OTHER | 0 | — | — | Form 4 | |
| Stout Stephen | See Remarks | Aug 25, 2025 | AWARD | 12,805 | $0.87 | $11.1K | Form 4 |
| Stout Stephen | See Remarks | Aug 25, 2025 | AWARD | 12,805 | $1.08 | $13.9K | Form 4 |
| Neill Andrew R | Chief Financial Officer | Aug 25, 2025 | AWARD | 64,027 | $0.87 | $55.6K | Form 4 |
| Neill Andrew R | Chief Financial Officer | Aug 25, 2025 | AWARD | 64,027 | $1.08 | $69.4K | Form 4 |
| SIEGALL CLAY B | director | Aug 25, 2025 | AWARD | 128,054 | $0.87 | $111.1K | Form 4 |
| SIEGALL CLAY B | director | Aug 25, 2025 | AWARD | 128,054 | $1.08 | $138.9K | Form 4 |
| Schreiber Taylor | director, officer: Chief Executive Officer | Aug 25, 2025 | AWARD | 25,610 | $0.87 | $22.2K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Aug 25, 2025 | AWARD | 5,122 | $0.87 | $4.4K | Form 4 |
| Schreiber Taylor | director, officer: Chief Executive Officer | Aug 25, 2025 | AWARD | 25,610 | $1.08 | $27.8K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Aug 25, 2025 | AWARD | 5,122 | $1.08 | $5.6K | Form 4 |
| Redmile Group, LLC | director, 10 percent owner: | Aug 25, 2025 | AWARD | 4,097,730 | $0.00 | $409.77 | Form 4 |
| Redmile Group, LLC | director, 10 percent owner: | Aug 25, 2025 | AWARD | 4,097,730 | $1.08 | $4.4M | Form 4 |
| Lee Michael Stewart | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Redmile Group, LLC | director, 10 percent owner: | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| SIEGALL CLAY B | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Sasser Amy Kate | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Golumbeski George | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Gibson Neil W | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Brownstein Carrie | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Brous Tyler | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Boudreau Helen M | director | Jul 14, 2025 | AWARD | 33,150 | $0.82 | $27.2K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jan 28, 2025 | AWARD | 165,200 | $1.18 | $194.9K | Form 4 |
| Shukla Abhinav A. | Chief Technical Officer | Jan 25, 2025 | TAX W/H | 2,261 | $1.16 | $2.6K | Form 4 |
| DeYoung Casi | Chief Business Officer | Jan 28, 2025 | AWARD | 194,300 | $1.18 | $229.3K | Form 4 |
| DeYoung Casi | Chief Business Officer | Jan 25, 2025 | TAX W/H | 2,297 | $1.16 | $2.7K | Form 4 |